1932
0
  1. Home
  2. A-Z Publications
  3. Annual Review of Medicine
  4. Volume 71, 2020
  5. Article

Annual Review of Medicine

Volume 71, 2020

Transcatheter Mitral Valve Replacement: Rationale and Current Status

Abstract

Mitral regurgitation (MR) is the most prevalent form of moderate or severe valve disease in the developed world. MR can result from impairment of any part of the mitral valve apparatus and is classified as primary (disease of the leaflets) or secondary (functional). The presence of at least moderate MR is associated with increased morbidity and mortality. With the goal of avoiding the risks of traditional surgery, transcatheter mitral valve therapies have been developed. The current transcatheter repair techniques are limited by therapeutic target and incomplete MR reduction, and thus transcatheter mitral valve replacement (TMVR) has been pursued. Several devices (both transapical and transseptal) are under development, with both early feasibility and pivotal trials under way. As this field develops, the decision to treat with TMVR will require a heart team approach that takes patient-, disease-, and device-specific factors into account.

Keyword(s): mitral regurgitation, mitral valve replacement, mitral valve surgery, TMVR, transcatheter valve therapies
Loading

Article metrics loading...

/content/journals/10.1146/annurev-med-051418-060028
2020-01-27
2024-04-24
Loading full text...

Full text loading...

/deliver/fulltext/med/71/1/annurev-med-051418-060028.html?itemId=/content/journals/10.1146/annurev-med-051418-060028&mimeType=html&fmt=ahah

Literature Cited

  1. 1. 
    Coffey S, Cairns BJ, Iung B 2016. The modern epidemiology of heart valve disease. Heart 102:75–85
     [Google Scholar]
  2. 2. 
    Benjamin EJ, Virani SS, Callaway CW et al. 2018. Heart disease and stroke statistics—2018 update: a report from the American Heart Association. Circulation 137:e67–492
     [Google Scholar]
  3. 3. 
    Nkomo VT, Gardin JM, Skelton TN et al. 2006. Burden of valvular heart diseases: a population-based study. Lancet 368:1005–11
     [Google Scholar]
  4. 4. 
    Chaput M, Handschumacher MD, Tournoux F et al. 2008. Mitral leaflet adaptation to ventricular remodeling: occurrence and adequacy in patients with functional mitral regurgitation. Circulation 118:845–52
     [Google Scholar]
  5. 5. 
    Magida MG, Streitfeld FH. 1957. The natural history of rheumatic heart disease in the third, fourth, and fifth decades of life. II. Prognosis with special reference to morbidity. Circulation 16:713–22
     [Google Scholar]
  6. 6. 
    Horstkotte D, Loogen F, Kleikamp G et al. 1983. [Effect of prosthetic heart valve replacement on the natural course of isolated mitral and aortic as well as multivalvular diseases. Clinical results in 783 patients up to 8 years following implantation of the Björk-Shiley tilting disc prosthesis]. Z. Kardiol. 72:494–503. In German
     [Google Scholar]
  7. 7. 
    Ling LH, Enriquez-Sarano M, Seward JB et al. 1996. Clinical outcome of mitral regurgitation due to flail leaflet. N. Engl. J. Med. 335:1417–23
     [Google Scholar]
  8. 8. 
    Trichon BH, Felker GM, Shaw LK et al. 2003. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am. J. Cardiol. 91:538–43
     [Google Scholar]
  9. 9. 
    Lamas GA, Mitchell GF, Flaker GC et al. 1997. Clinical significance of mitral regurgitation after acute myocardial infarction. Circulation 96:827–33
     [Google Scholar]
  10. 10. 
    Grigioni F, Enriquez-Sarano M, Zehr KJ et al. 2001. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 103:1759–64
     [Google Scholar]
  11. 11. 
    Sannino A, Smith RL, Schiattarella GG et al. 2017. Survival and cardiovascular outcomes of patients with secondary mitral regurgitation: a systematic review and meta-analysis. JAMA Cardiol 2:1130–39
     [Google Scholar]
  12. 12. 
    Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D et al. 2005. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N. Engl. J. Med. 352:875–83
     [Google Scholar]
  13. 13. 
    Nishimura RA, Otto CM, Bonow RO et al. 2017. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 70:252–89
     [Google Scholar]
  14. 14. 
    Vahanian A, Alfieri O, Andreotti F et al. 2012. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur. J. Cardiothorac. Surg. 42:S1–44
     [Google Scholar]
  15. 15. 
    Yun KL, Miller DC. 1991. Mitral valve repair versus replacement. Cardiol. Clin. 9:315–27
     [Google Scholar]
  16. 16. 
    Vassileva CM, Mishkel G, McNeely C et al. 2013. Long-term survival of patients undergoing mitral valve repair and replacement: a longitudinal analysis of Medicare fee-for-service beneficiaries. Circulation 127:1870–76
     [Google Scholar]
  17. 17. 
    Castillo JG, Anyanwu AC, Fuster V, Adams DH 2012. A near 100% repair rate for mitral valve prolapse is achievable in a reference center: implications for future guidelines. J. Thorac. Cardiovasc. Surg. 144:308–12
     [Google Scholar]
  18. 18. 
    Jouan J, Berrebi A, Chauvaud S et al. 2012. Mitral valve reconstruction in Barlow disease: long-term echographic results and implications for surgical management. J. Thorac. Cardiovasc. Surg. 143:S17–20
     [Google Scholar]
  19. 19. 
    Gillinov AM, Blackstone EH, Nowicki ER et al. 2008. Valve repair versus valve replacement for degenerative mitral valve disease. J. Thorac. Cardiovasc. Surg. 135:885–93.e2
     [Google Scholar]
  20. 20. 
    Braunberger E, Deloche A, Berrebi A et al. 2001. Very long-term results (more than 20 years) of valve repair with Carpentier's techniques in nonrheumatic mitral valve insufficiency. Circulation 104:I8–11
     [Google Scholar]
  21. 21. 
    DiBardino DJ, ElBardissi AW, McClure RS et al. 2010. Four decades of experience with mitral valve repair: analysis of differential indications, technical evolution, and long-term outcome. J. Thorac. Cardiovasc. Surg. 139:76–83
     [Google Scholar]
  22. 22. 
    Gillinov AM, Wierup PN, Blackstone EH et al. 2001. Is repair preferable to replacement for ischemic mitral regurgitation?. J. Thorac. Cardiovasc. Surg. 122:1125–41
     [Google Scholar]
  23. 23. 
    Reece TB, Tribble CG, Ellman PI et al. 2004. Mitral repair is superior to replacement when associated with coronary artery disease. Ann. Surg. 239:671–75
     [Google Scholar]
  24. 24. 
    Al-Radi OO, Austin PC, Tu JV et al. 2005. Mitral repair versus replacement for ischemic mitral regurgitation. Ann. Thorac. Surg. 79:1260–67
     [Google Scholar]
  25. 25. 
    Di Salvo TG, Acker MA, Dec GW, Byrne JG 2010. Mitral valve surgery in advanced heart failure. J. Am. Coll. Cardiol. 55:271–82
     [Google Scholar]
  26. 26. 
    Acker MA, Parides MK, Perrault LP et al. 2014. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N. Engl. J. Med. 370:23–32
     [Google Scholar]
  27. 27. 
    Smith CR, Leon MB, Mack MJ et al. 2011. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N. Engl. J. Med. 364:2187–98
     [Google Scholar]
  28. 28. 
    Leon MB, Smith CR, Mack MJ et al. 2016. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N. Engl. J. Med. 374:1609–20
     [Google Scholar]
  29. 29. 
    Gammie JS, O'Brien SM, Griffith BP et al. 2007. Influence of hospital procedural volume on care process and mortality for patients undergoing elective surgery for mitral regurgitation. Circulation 115:881–87
     [Google Scholar]
  30. 30. 
    Mehta RH, Eagle KA, Coombs LP et al. 2002. Influence of age on outcomes in patients undergoing mitral valve replacement. Ann. Thorac. Surg. 74:1459–67
     [Google Scholar]
  31. 31. 
    Goodney PP, Stukel TA, Lucas FL et al. 2003. Hospital volume, length of stay, and readmission rates in high-risk surgery. Ann. Surg. 238:161–67
     [Google Scholar]
  32. 32. 
    Mihaljevic T, Lam BK, Rajeswaran J et al. 2007. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J. Am. Coll. Cardiol. 49:2191–201
     [Google Scholar]
  33. 33. 
    Wu AH, Aaronson KD, Bolling SF et al. 2005. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J. Am. Coll. Cardiol. 45:381–87
     [Google Scholar]
  34. 34. 
    Goel SS, Bajaj N, Aggarwal B et al. 2014. Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: comprehensive analysis to determine the potential role of MitraClip for this unmet need. J. Am. Coll. Cardiol. 63:185–86
     [Google Scholar]
  35. 35. 
    Mirabel M, Iung B, Baron G et al. 2007. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery?. Eur. Heart J. 28:1358–65
     [Google Scholar]
  36. 36. 
    Rosendal C, Hien MD, Bruckner T et al. 2012. Left ventricular outflow tract: intraoperative measurement and changes caused by mitral valve surgery. J. Am. Soc. Echocardiogr. 25:166–72
     [Google Scholar]
  37. 37. 
    Guerrero M, Dvir D, Himbert D et al. 2016. Transcatheter mitral valve replacement in native mitral valve disease with severe mitral annular calcification: results from the first multicenter global registry. JACC Cardiovasc. Interv. 9:1361–71
     [Google Scholar]
  38. 38. 
    Paradis JM, Del Trigo M, Puri R, Rodés-Cabau J 2015. Transcatheter valve-in-valve and valve-in-ring for treating aortic and mitral surgical prosthetic dysfunction. J. Am. Coll. Cardiol. 66:2019–37
     [Google Scholar]
  39. 39. 
    Inderbitzin DT, Taramasso M, Nietlispach F, Maisano F 2016. Mitral valve repair versus replacement: Is it a different story for percutaneous compared to surgical valve therapy?. J. Cardiovasc. Surg. 57:410–20
     [Google Scholar]
  40. 40. 
    Maisano F, Alfieri O, Banai S et al. 2015. The future of transcatheter mitral valve interventions: competitive or complementary role of repair versus replacement?. Eur. Heart J. 36:1651–59
     [Google Scholar]
  41. 41. 
    Seiffert M, Franzen O, Conradi L et al. 2010. Series of transcatheter valve-in-valve implantations in high-risk patients with degenerated bioprostheses in aortic and mitral position. Catheter. Cardiovasc. Interv. 76:608–15
     [Google Scholar]
  42. 42. 
    Webb JG, Wood DA, Ye J et al. 2010. Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation 121:1848–57
     [Google Scholar]
  43. 43. 
    Cheung AW, Gurvitch R, Ye J et al. 2011. Transcatheter transapical mitral valve-in-valve implantations for a failed bioprosthesis: a case series. J. Thorac. Cardiovasc. Surg. 141:711–15
     [Google Scholar]
  44. 44. 
    Gaia DF, Palma JH, de Souza JA et al. 2012. Transapical mitral valve-in-valve implant: an alternative for high risk and multiple reoperative rheumatic patients. Int. J. Cardiol. 154:e6–7
     [Google Scholar]
  45. 45. 
    Himbert D, Brochet E, Radu C et al. 2011. Transseptal implantation of a transcatheter heart valve in a mitral annuloplasty ring to treat mitral repair failure. Circ. Cardiovasc. Interv. 4:396–98
     [Google Scholar]
  46. 46. 
    Descoutures F, Himbert D, Maisano F et al. 2013. Transcatheter valve-in-ring implantation after failure of surgical mitral repair. Eur. J. Cardiothorac. Surg. 44:e8–15
     [Google Scholar]
  47. 47. 
    Wunderlich NC, Kische S, Ince H, Bozdağ-Turan I 2014. Transcatheter valve-in-ring implantation after a failed surgical mitral repair using a transseptal approach and a veno-arterial loop for valve placement. Catheter. Cardiovasc. Interv. 84:1202–8
     [Google Scholar]
  48. 48. 
    Guerrero M, Urena M, Pursnani A et al. 2016. Balloon expandable transcatheter heart valves for native mitral valve disease with severe mitral annular calcification. J. Cardiovasc. Surg. 57:401–9
     [Google Scholar]
  49. 49. 
    Yoon SH, Whisenant BK, Bleiziffer S et al. 2019. Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. Eur. Heart J. 40:441–51
     [Google Scholar]
  50. 50. 
    Kodali S, Pibarot P, Douglas PS et al. 2015. Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards Sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. Eur. Heart J. 36:449–56
     [Google Scholar]
  51. 51. 
    Athappan G, Patvardhan E, Tuzcu EM et al. 2013. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J. Am. Coll. Cardiol. 61:1585–95
     [Google Scholar]
  52. 52. 
    De Backer O, Piazza N, Banai S et al. 2014. Percutaneous transcatheter mitral valve replacement: an overview of devices in preclinical and early clinical evaluation. Circ. Cardiovasc. Interv. 7:400–9
     [Google Scholar]
  53. 53. 
    Regueiro A, Granada JF, Dagenais F, Rodés-Cabau J 2017. Transcatheter mitral valve replacement: insights from early clinical experience and future challenges. J. Am. Coll. Cardiol. 69:2175–92
     [Google Scholar]
  54. 54. 
    Muller DWM, Farivar RS, Jansz P et al. 2017. Transcatheter mitral valve replacement for patients with symptomatic mitral regurgitation: a global feasibility trial. J. Am. Coll. Cardiol. 69:381–91
     [Google Scholar]
  55. 55. 
    Sorajja P, Moat N, Badhwar V et al. 2019. Initial feasibility study of a new transcatheter mitral prosthesis: the first 100 patients. J. Am. Coll. Cardiol. 73:1250–60
     [Google Scholar]
  56. 56. 
    Bapat V, Rajagopal V, Meduri C et al. 2018. Early experience with new transcatheter mitral valve replacement. J. Am. Coll. Cardiol. 71:12–21
     [Google Scholar]
  57. 57. 
    Cheung A. 2018. Early experience of TIARA transcatheter mitral valve replacement system. Ann. Cardiothorac. Surg. 7:787–91
     [Google Scholar]
  58. 58. 
    Sondergaard L, Ussia GP, Dumonteil N, Quadri A 2015. The CardiAQ transcatheter mitral valve implantation system. EuroIntervention 11: Suppl. W 76–77
     [Google Scholar]
  59. 59. 
    Webb JG, Murdoch DJ, Boone RH et al. 2019. Percutaneous transcatheter mitral valve replacement: first-in-human experience with a new transseptal system. J. Am. Coll. Cardiol. 73:1239–46
     [Google Scholar]
/content/journals/10.1146/annurev-med-051418-060028
Loading
Transcatheter Mitral Valve Replacement: Rationale and Current Status
Annual Review of Medicine 71, 249 (2020); https://doi.org/10.1146/annurev-med-051418-060028
/content/journals/10.1146/annurev-med-051418-060028
/content/journals/10.1146/annurev-med-051418-060028
Loading

Data & Media loading...

  • Article Type: Review Article

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error